Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study Of BIBF 1120 as Second-line Treatment for Patients With Small Cell Lung Cancer

NCT01441297 is registered in ClinicalTrials.gov with Ji-youn Han as lead sponsor.

NCT NCT01441297
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01441297 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study Of BIBF 1120 as Second-line Treatment for Patients With Small Cell Lung Cancer
Lead sponsor
Ji-youn Han
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2011
Completion date
March 31, 2016
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

small cell lung cancer, small cell lung cancer recurrent